0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing spondylitis" gave back 131 results.
Ankylosing Spondylitis Medication is a drug used to relieve or treat ankylosing spondylitis. The global Ankylosing Spondylitis Medication market is...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Ankylosing Spondylitis Medication is a drug used to relieve or treat ankylosing spondylitis. The global Ankylosing Spondylitis Medication market is...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Ankylosing Spondylitis Treatment Drug Market The global Ankylosing Spondylitis Treatment Drug market is...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Ankylosing Spondylitis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Summary Ankylosing Spondylitis market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
January 2024
Price: USD 2,960.00
Highlights The global Ankylosing Spondylitis Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Ankylosing Spondylitis Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Biosimilar Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
